L'Air Liquide S.A. (AIQUF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
L'Air Liquide S.A. (AIQUF) with AI Score 44/100 (Weak). L'Air Liquide S. A. is a global leader in gases, technologies, and services for industry and health. Market cap: 0, Sector: Basic materials.
Last analyzed: Mar 16, 2026L'Air Liquide S.A. (AIQUF) Materials & Commodity Exposure
L'Air Liquide S.A., founded in 1902, is a multinational corporation supplying gases, technologies, and services to industrial and healthcare sectors globally. With a market cap of $115.10B, the company focuses on gases, engineering, and advanced technologies, serving diverse industries from metals to healthcare, while investing in energy transition and clean mobility solutions.
Investment Thesis
L'Air Liquide S.A. presents a compelling investment case driven by its essential product offerings and diversified market presence. The company's focus on gases and related services caters to a wide range of industries, providing a stable revenue base. With a market capitalization of $115.10B and a profit margin of 13.1%, L'Air Liquide demonstrates financial strength. The company's investments in energy transition technologies, particularly in hydrogen and biomethane, align with global sustainability trends, positioning it for long-term growth. Key catalysts include increasing demand for industrial gases and expansion in emerging markets. However, investors may want to evaluate potential risks such as fluctuations in raw material prices and regulatory changes.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $115.10B reflects the company's strong market position and investor confidence.
- Profit Margin of 13.1% indicates efficient operations and profitability.
- Gross Margin of 64.2% demonstrates the company's ability to maintain high pricing power.
- Return on Equity (ROE) of 13.4% signifies effective utilization of shareholder equity.
- Debt-to-Equity Ratio of 50.66 indicates a balanced capital structure.
Competitors & Peers
Strengths
- Global leader in industrial and medical gases.
- Diversified product portfolio and customer base.
- Strong technological capabilities and innovation.
- Established presence in key markets.
Weaknesses
- Exposure to fluctuations in raw material prices.
- Dependence on capital-intensive operations.
- Sensitivity to economic cycles.
- Complexity of global operations.
Catalysts
- Ongoing: Increasing demand for industrial gases in emerging markets.
- Ongoing: Expansion of hydrogen energy infrastructure and applications.
- Ongoing: Growing adoption of carbon capture and storage technologies.
- Upcoming: Potential government incentives for renewable energy projects.
- Upcoming: New partnerships and collaborations in key markets.
Risks
- Potential: Fluctuations in raw material prices impacting profitability.
- Potential: Regulatory changes and environmental regulations affecting operations.
- Potential: Economic downturns and market volatility reducing demand.
- Ongoing: Intense competition from other gas suppliers.
- Ongoing: Geopolitical risks and supply chain disruptions.
Growth Opportunities
- Growth opportunity 1: Expansion in Hydrogen Energy: L'Air Liquide is strategically positioned to capitalize on the growing demand for hydrogen as a clean energy source. The company is investing in hydrogen production, distribution, and infrastructure, targeting applications in transportation, industry, and power generation. The global hydrogen market is projected to reach $201 billion by 2030, offering significant growth potential for L'Air Liquide. The company's expertise in gas management and infrastructure development provides a competitive advantage in this rapidly expanding market.
- Growth opportunity 2: Healthcare Sector Expansion: The increasing demand for medical gases and healthcare services presents a significant growth opportunity for L'Air Liquide. The company's focus on providing medical gases, hygiene products, and related services to hospitals and home-based patients aligns with the aging global population and rising healthcare expenditures. The global medical gases market is expected to reach $14.9 billion by 2027. L'Air Liquide's established presence in the healthcare sector and its focus on innovation position it well to capture a larger market share.
- Growth opportunity 3: Emerging Markets Penetration: L'Air Liquide can drive growth by expanding its presence in emerging markets, particularly in Asia Pacific and Latin America. These regions are experiencing rapid industrialization and urbanization, leading to increased demand for industrial gases and related services. By establishing strategic partnerships and investing in local infrastructure, L'Air Liquide can tap into these high-growth markets. The company's global expertise and technological capabilities provide a competitive edge in serving the diverse needs of emerging market customers.
- Growth opportunity 4: Carbon Capture and Storage (CCS) Technologies: As industries face increasing pressure to reduce carbon emissions, L'Air Liquide can leverage its expertise in gas management to develop and deploy carbon capture and storage technologies. CCS involves capturing carbon dioxide emissions from industrial sources and storing them underground, preventing them from entering the atmosphere. The global CCS market is projected to grow significantly, driven by government regulations and corporate sustainability initiatives. L'Air Liquide's technological capabilities and partnerships with industrial companies position it to capitalize on this emerging market.
- Growth opportunity 5: Biomethane Production: L'Air Liquide's investment in biomethane production units presents a growth opportunity aligned with the increasing demand for renewable energy sources. Biomethane, produced from organic waste, can be used as a substitute for natural gas in various applications. The company's expertise in gas processing and distribution enables it to efficiently produce and deliver biomethane to customers. The global biomethane market is expected to grow substantially, driven by government incentives and environmental concerns. L'Air Liquide's focus on sustainable energy solutions positions it well to benefit from this trend.
Opportunities
- Growing demand for hydrogen and clean energy solutions.
- Expansion in emerging markets.
- Increasing demand for medical gases and healthcare services.
- Development of carbon capture and storage technologies.
Threats
- Intense competition from other gas suppliers.
- Regulatory changes and environmental regulations.
- Economic downturns and market volatility.
- Geopolitical risks and supply chain disruptions.
Competitive Advantages
- Strong global presence and established infrastructure.
- Extensive portfolio of industrial and medical gases.
- Technological expertise in gas management and energy transition.
- Long-term relationships with key customers.
- High barriers to entry due to capital-intensive operations.
About AIQUF
L'Air Liquide S.A., established in 1902 and headquartered in Paris, France, is a global leader in providing gases, technologies, and services to a wide array of industries, including industrial and healthcare sectors. The company operates across Europe, the Americas, Asia Pacific, the Middle East, and Africa. Its Gas & Services segment, the core of its operations, offers essential gases such as oxygen, nitrogen, argon, hydrogen, and carbon monoxide. These gases are critical for sectors like metals, chemicals, refining, and energy. Additionally, the segment provides application equipment and related services to industries including materials and energy, automotive and manufacturing, food and pharmaceuticals, technology and research, and retail. In the healthcare sector, L'Air Liquide supplies medical gases, hygiene products, equipment, and services to hospitals and home-based patients. It also produces and distributes specialty ingredients for the cosmetics, pharmaceutical, and vaccine markets. The company's Engineering & Construction segment designs, develops, and builds industrial gas production plants for third parties, as well as plants for the traditional, renewable, and alternative energy sectors. The Global Markets & Technologies segment focuses on delivering technological solutions to support energy transition, including transport, energy, and waste valorization, along with deep tech applications in space exploration, aerospace, and big science. This segment also invests in biomethane production units and develops stations for distributing natural bio-gas and hydrogen for clean mobility, while supplying gases for offshore oil and gas platforms and wind turbines. L'Air Liquide's diverse portfolio and global presence solidify its position as a key player in the industrial and healthcare sectors.
What They Do
- Supplies industrial gases like oxygen, nitrogen, argon, and hydrogen.
- Provides medical gases, hygiene products, and healthcare services.
- Designs and builds industrial gas production plants.
- Offers engineering and construction services for energy sector.
- Develops technologies for energy transition and clean mobility.
- Invests in biomethane production units.
- Supplies gases for offshore oil and gas platforms and wind turbines.
Business Model
- Sells industrial and medical gases to various industries.
- Provides engineering and construction services for gas production plants.
- Offers technology solutions for energy transition and clean mobility.
- Generates revenue from biomethane production and distribution.
Industry Context
L'Air Liquide S.A. operates in the specialty chemicals industry, which is characterized by high barriers to entry due to the capital-intensive nature of gas production and distribution. The industry is influenced by macroeconomic factors, technological advancements, and environmental regulations. Key trends include increasing demand for industrial gases in emerging markets and growing focus on sustainable solutions such as hydrogen and carbon capture. L'Air Liquide competes with companies like Linde and Air Products, striving to maintain its market share through innovation and strategic partnerships. The global industrial gases market is projected to grow steadily, driven by demand from manufacturing, healthcare, and energy sectors.
Key Customers
- Metals, chemicals, refining, and energy sectors.
- Hospitals and healthcare providers.
- Automotive and manufacturing industries.
- Technology and research sectors.
Financials
Chart & Info
L'Air Liquide S.A. (AIQUF) stock price: Price data unavailable
Latest News
-
L'Air Liquide: Margin Visibility And Execution Drive A Positive Re-Rating
seekingalpha.com · Feb 26, 2026
-
$56.64 Bn Biomethane Market by Feedstock, Production Process, End-use, Region - Global Forecast to 2030: Market to Grow at a CAGR of 28%
Yahoo! Finance: AIQUF News · Feb 25, 2026
-
Green Hydrogen Industry Research and Global Forecast Report 2025-2032: Market to Grow at a CAGR of 60%, Driven by Emergence of Hubs & Industrial Clusters, and Grid Balancing & Energy Storage
Yahoo! Finance: AIQUF News · Feb 25, 2026
-
L'Air Liquide Margin Record And Dividend Rise Test Earnings Resilience
Yahoo! Finance: AIQUF News · Feb 24, 2026
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AIQUF.
Price Targets
Wall Street price target analysis for AIQUF.
MoonshotScore
What does this score mean?
The MoonshotScore rates AIQUF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
L'Air Liquide: Margin Visibility And Execution Drive A Positive Re-Rating
$56.64 Bn Biomethane Market by Feedstock, Production Process, End-use, Region - Global Forecast to 2030: Market to Grow at a CAGR of 28%
Green Hydrogen Industry Research and Global Forecast Report 2025-2032: Market to Grow at a CAGR of 60%, Driven by Emergence of Hubs & Industrial Clusters, and Grid Balancing & Energy Storage
L'Air Liquide Margin Record And Dividend Rise Test Earnings Resilience
Leadership: Francois Jackow
Chairman and Chief Executive Officer
Francois Jackow has served as the Chairman and Chief Executive Officer of L'Air Liquide S.A. since June 1, 2022. He brings extensive experience in the industrial gases sector. Before assuming his current role, he held various leadership positions within L'Air Liquide, including Deputy CEO and Executive Vice President. His career spans over two decades with the company, during which he has been instrumental in driving innovation and growth. He is known for his strategic vision and commitment to sustainability.
Track Record: Under Francois Jackow's leadership, L'Air Liquide has focused on strengthening its position in the hydrogen energy market and expanding its presence in emerging economies. He has overseen significant investments in renewable energy technologies and carbon capture solutions. His strategic decisions have contributed to the company's financial performance and its commitment to environmental sustainability. He is managing 64124 employees.
AIQUF OTC Market Information
The OTC Other tier represents the lowest tier of over-the-counter (OTC) markets, indicating that L'Air Liquide S.A. (AIQUF) may have limited regulatory oversight and reporting requirements compared to companies listed on major exchanges like the NYSE or NASDAQ. Companies in this tier often do not meet the minimum financial standards or disclosure requirements necessary for exchange listing. Investors should be aware that stocks in this tier typically carry higher risks due to the potential for less transparency and regulatory scrutiny.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited regulatory oversight and disclosure requirements.
- Potential for lower liquidity and wider bid-ask spreads.
- Increased price volatility due to lower trading volumes.
- Higher risk of fraud or manipulation compared to listed exchanges.
- Limited availability of reliable financial information.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Check for any regulatory actions or legal disputes.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- Established history as L'Air Liquide S.A., founded in 1902.
- Global operations across multiple continents.
- Presence in critical industries such as healthcare and energy.
- Significant market capitalization, though traded on OTC.
- Continued operations despite OTC listing.
AIQUF Basic Materials Stock FAQ
What does L'Air Liquide S.A. do?
L'Air Liquide S.A. is a global leader in providing gases, technologies, and services to the industrial and healthcare sectors. The company's core business involves producing and distributing essential gases such as oxygen, nitrogen, argon, and hydrogen. These gases are used in a wide range of applications, including manufacturing, healthcare, energy, and environmental protection. Additionally, L'Air Liquide offers engineering and construction services for gas production plants and develops innovative technologies for energy transition and clean mobility. The company serves a diverse customer base across Europe, the Americas, Asia Pacific, the Middle East, and Africa.
What do analysts say about AIQUF stock?
Analyst consensus on AIQUF stock is pending. Key valuation metrics include a P/E ratio of 28.03, reflecting investor expectations for future earnings growth. The company's profit margin of 13.1% and gross margin of 64.2% indicate strong profitability and pricing power. Growth considerations include the company's investments in hydrogen energy and emerging markets. Investors should monitor these factors to assess the potential for future stock performance. Note that AIQUF trades on the OTC market, which may affect analyst coverage and liquidity.
What are the main risks for AIQUF?
The main risks for L'Air Liquide S.A. include fluctuations in raw material prices, which can impact profitability. Regulatory changes and environmental regulations may also affect the company's operations and increase compliance costs. Economic downturns and market volatility can reduce demand for industrial gases and related services. Intense competition from other gas suppliers poses a threat to market share. Geopolitical risks and supply chain disruptions can also impact the company's global operations. Additionally, the OTC listing introduces risks related to liquidity and disclosure.
What are the key factors to evaluate for AIQUF?
L'Air Liquide S.A. (AIQUF) currently holds an AI score of 44/100, indicating low score. Key strength: Global leader in industrial and medical gases.. Primary risk to monitor: Potential: Fluctuations in raw material prices impacting profitability.. This is not financial advice.
How frequently does AIQUF data refresh on this page?
AIQUF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven AIQUF's recent stock price performance?
Recent price movement in L'Air Liquide S.A. (AIQUF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Global leader in industrial and medical gases.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider AIQUF overvalued or undervalued right now?
Determining whether L'Air Liquide S.A. (AIQUF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying AIQUF?
Before investing in L'Air Liquide S.A. (AIQUF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on available information and may be subject to change.
- OTC market data may have limited availability and reliability.
- Analyst consensus is pending and may vary.